Site-Wide License
Showing 253–264 of 279 results
-
CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)
$6,800.00 – $13,600.00 -
Optimizing Feasibility in Clinical Trials
$2,460.00 – $4,920.00 -
US Payers: Comparative Effectiveness Research (CER) and Formulary Decision-making
$4,900.00 – $9,800.00 -
Electronic Detailing vs. In-person Detailing (US)
$4,900.00 – $9,800.00 -
Primer: A View of Biosimilars from the Pharmacy
$475.00 – $700.00 -
Clinical Imaging Market Dynamics and Service Provider Performance
$1,490.00 – $2,980.00 -
Cardiac Safety / ECG Market Dynamics and Service Provider Performance
$3,460.00 – $5,190.00 -
Improving Adherence and Compliance: The Pharmacist’s View
$4,900.00 – $7,350.00 -
Post-marketing Safety Market Overview and Outlook
$4,900.00 – $7,350.00 -
The Phase I Market Overview and Outlook
$4,900.00 – $7,350.00 -
CRO Quality Benchmarking Report (3rd edition)
$6,800.00 – $10,200.00 -
CRO Selection for Small Pharma and Biotech (2011)
$2,460.00 – $3,690.00
